Abbott Snags U.S. Clearance To Enter The Obesity Arena, Rivaling Dexcom

Abbott Laboratories gained U.S. clearance Monday for a pair of new CGMs. But Abbott stock fell a fraction at the close.
The post Abbott Snags U.S. Clearance To Enter The Obesity Arena, Rivaling Dexcom appeared first on Investor's Business Daily.